Related Experiment Video
Updated: May 19, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Screening practices for diabetic peripheral neuropathy in pediatric type 1 diabetes: a nationwide survey by the ISPED
Bruno Bombaci1, Marta Bassi2, Valeria Castorani3
1Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, Messina, Italy.
Insights
Diabetic peripheral neuropathy screening is inconsistent in Italian pediatric diabetes centers, with many delaying diagnosis. Improved training and national protocols are needed for timely identification in children with type 1 diabetes.
Area of Science:
- Pediatric Endocrinology
- Neurology
- Public Health
Background:
- Diabetic peripheral neuropathy (DN) is a significant complication of type 1 diabetes (T1D), often presenting subclinically in pediatric populations.
- International guidelines advocate for annual DN screening in youth with T1D, but adherence remains uncertain.
- Early detection of DN is crucial for preventing long-term complications and ensuring optimal patient outcomes.
Purpose of the Study:
- To evaluate the current practices and adherence to DN screening guidelines in Italian pediatric diabetes centers.
- To identify organizational barriers and challenges hindering the implementation of consistent DN screening protocols.
- To assess the level of professional training and awareness regarding DN screening among healthcare providers.
Main Methods:
- A nationwide, cross-sectional survey was conducted among Italian pediatric diabetes centers affiliated with the ISPED Diabetes Study Group.
- A 27-item questionnaire gathered data on organizational features, DN screening practices, and professional training.
- Data were analyzed to determine the extent of adherence to recommended screening criteria and methods.
Main Results:
- Only 18.6% of centers reported annual DN screening, with over 40% initiating screening only upon symptom onset.
- Adherence to recommended screening criteria (age ≥ 11 years, 2-5 years diabetes duration) was observed in 31.3% of centers.
- A significant majority (89.6%) of respondents lacked formal training in DN screening, and nerve conduction studies and the Michigan Neuropathy Screening Instrument were underutilized.
Conclusions:
- DN screening practices in Italian pediatric diabetology are inconsistent and often delayed, potentially leading to underdiagnosis of early neuropathic changes.
- There is a critical need to enhance professional awareness, implement structured training programs, and establish harmonized national protocols for DN screening.
- These interventions are essential for ensuring timely identification and equitable management of DN in children and adolescents with T1D.
Aims:
Diabetic peripheral neuropathy (DN) is a major complication of type 1 diabetes (T1D), frequently subclinical in youth. Although international pediatric guidelines recommend annual screening, adherence in pediatric care is uncertain. This study aimed to assess DN screening practices in Italian pediatric diabetes centers and identify barriers to implementation.
Methods:
Between December 2024 and May 2025, we conducted a nationwide, cross-sectional survey among Italian centers affiliated with the ISPED Diabetes Study Group. One respondent per center completed a 27-item questionnaire exploring organizational features, DN screening practices, and professional training.
Results:
Forty-eight centers responded to the survey. Written internal protocols for DN screening were available in 22.9% of centers. Only 18.6% reported annual screening, while more than 40% initiated screening only in the presence of symptoms. Recommended criteria (age ≥ 11 years and 2-5 years diabetes duration) were applied by 31.3% of centers. Clinical neurological examination was widely adopted (95.8%), whereas nerve conduction studies (29.2%) and the Michigan Neuropathy Screening Instrument (14.6%) were rarely used. Notably, 89.6% of respondents had never received formal training in DN screening. Centers where pediatric diabetologists personally conducted the assessment were more likely to adhere to annual screening (p = 0.010).
Conclusions:
Screening for DN in Italian pediatric diabetology is inconsistent and frequently delayed, contributing to probable underrecognition of early neuropathic changes. Strengthening professional awareness, promoting structured training, and implementing harmonized national protocols are essential steps to ensure timely identification and equitable care for children and adolescents with T1D.
Related Concept Videos
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetes: Symptoms, Diagnosis, and Complications
Diabetic Neuropathy
Diabetic Retinopathy
Diabetes Mellitus: Type 2 and Gestational

